Moderna stock price sits at $94

Moderna stock price sits at $94.60 after a choppy start to the week. Options market data shows increased open interest in June call contracts, signaling bullish sentiment among speculative traders. We're getting everything ready for you. The page is loading, and you'll be on your way in just a few moments. There's another reason that investors may want to dump their Moderna shares. Although mRNA has great long-term appeal, the political winds have shifted in the healthcare space. That has left companies like Moderna facing a situation where government support for medical research, particularly on the vaccine front, could be limited. Given that it is still early in the new administration, this is a significant issue that has at least a few years to run. And that, in turn, could mean weak financial results or, at the very least, a growth headwind for the foreseeable future. Investors may want to put their cash into an investment with more compelling prospects, which echoes the theme of point number 3. Moderna stock price reached $97.20 on optimistic mRNA flu vaccine data updates. Investors are closely watching competitor trial results to gauge competitive positioning.